ROBERT RUFFOLO

Profile

First Name

: ROBERT

Middle Name

:

Last Name

: RUFFOLO

Related Companies
Titles
Company Name
Related People
DIRECTOR
X-VAX TECHNOLOGY, INC.
ISAAC BLECH, IAN T. CLARK, ANDREAS EGGERT, BRIAN D. FINN, WILLIAM A. HASELTINE, ROGER A. JEFFS, CLARE KAHN, RICHARD KENNEY, ROGER POMERANTZ, ROGER J. POMERANTZ, ROBERT R. RUFFOLO, MATTHEW R. STOBER, JACOB UITTENBOGAARD, ULF WIINBERG
DIRECTOR
ELICIO THERAPEUTICS, INC.
JULIAN ADAMS, CAROL ASHE, DANIEL BEHR, ISAAC BLECH, BEN BRONSTEIN, YEKATERINA CHUDNOVSKY, ROBERT CONNELLY, STEVE DEITCHER, DANIEL GEFFKEN, OFER GONEN, FRANK HALUSKA, CHRISTOPHER HAQQ, SATISH JINDAL, DAPHNE KARYDAS, ISAAC KOHLBERG, WILLIAM KOSTER, ANNETTE MATTHIES, ASSAF SEGAL, ALAN SHAW
DIRECTOR
ELUCIDA ONCOLOGY, INC.
GREGORY ADAMS, ELIEL BAYEVER, ISAAC BLECH, TIM BORIS, MICHELLE BRADBURY, ROBERT ESSNER, ROBERT A. ESSNER, GENO GERMANO, SOMAIYA IAN, STEVEN LARSON, KAI MA, NATALIE MACDONALD, SIGURDUR OLAFSSON, TERESA RESSEL, TERESA M. RESSEL, EDWARD ROSEN, ROBERT A. RUFFOLO, GARY SENDER, MICHAEL SMITH, MICHAEL T. SMITH, ULRICH WIESNER, DAVID ZACARDELLI
DIRECTOR
SAPIENCE THERAPEUTICS, INC.
ISAAC BLECH, BARRY KAPPEL, BARRY KAPPEL, PH.D., HOWARD PIEN, ROBERT RUFFOLO, PH.D., CHRISTIAN SCHADE, DAVID SCHEINBERG, DAVID SCHEINBERG, PH.D.
DIRECTOR
LB PHARMACEUTICALS INC
SIMON BASSEYN, ANNA ERAMO, VINCENT GRATTAN, RAJUL JAIN, REBECCA LUSE, RAN NUSSBAUM, MARC PANOFF, MARK PANOFF, PIERO POLI, ZACHARY PRENSKY, LAUREN STIPP, EDMUND SULLIVAN, ANDREW VAINO, CHEN YU
DIRECTOR
NACUITY PHARMACEUTICALS, INC.
ISAAC BLECH, DR. GERALD D. CAGLE, GERALD CAGLE, RICHARD CHIN, M.D., HALDEN CONNER, WILLIAM HALDEN CONNER, EMMETT CUNNINGHAM, JR., SANFORD J. HILLSBERG, RUSTY KELLEY, JAMI KERN, CHARLES LIESER, ROBIN STEEL, ROBIN STEELE, MICHAEL WALL, G. MICHAEL WALL, PH.D., DAVID WOHLBERG, DAVID J. WOHLBERG, BENJAMIN YERXA
DIRECTOR
SCIFLUOR LIFE SCIENCES, INC.
KERRIE BRADY, ROBERT DEMPSEY, D. SCOTT EDWARDS, DAVID SCOTT EDWARDS, BRUCE FAILING, WILLIAM H. KOSTER, BARBARA RYAN, BRENT SAUNDERS, BRENTON SAUNDERS, ROBIN STEELE, WILLIAM STEINKRAUSS, DAVID J. TANZER
DIRECTOR
OCUTERRA THERAPEUTICS, INC.
KERRIE BRADY, ROBERT DEMPSEY, D. SCOTT EDWARDS, DAVID SCOTT EDWARDS, BRUCE FAILING, WILLIAM H. KOSTER, BARBARA RYAN, BRENT SAUNDERS, BRENTON SAUNDERS, ROBIN STEELE, WILLIAM STEINKRAUSS, DAVID J. TANZER
DIRECTOR
ARIDIS PHARMACEUTICALS, INC.
ISAAC BLECH, JOHN BORGESON, ROBERT COUGHLIN, ROBERT K. COUGHLIN, PAUL-ANDRE DE LAME, CRAIG GIBBS, JOHN HAMILTON, FRED KURLAND, MIKE NAZAK, ERIC PATZER, ROBERT RUFFOLO, JR., ROBERT R. RUFFOLO, JR., VU TROUNG, VU TRUONG, SUSAN WINDHAM-BANNISTER
DIRECTOR
ELICIO THERAPEUTICS, INC.
JULIAN ADAMS, CAROL ASHE, YEKATERINA CHUDNOVSKY, ROBERT CONNELLY, PETER DEMUTH, VICTOR GANZI, ITZHAK D. GOLDBERG, CHRISTOPHER HAQQ, ALLEN NISSENSON, GIL OMENN, BRIAN PIEKOS, JAY VENKATESAN, JAY R. VENKATESAN, KAREN WILSON, MICHAEL YAMIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-03-19 
2024-02-22
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-12-14 
2024-01-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-29 
2024-01-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-22 
2023-12-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-12-14 
2023-09-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-29 
2023-08-03
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2023-05-24 
2023-06-15
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-05-24 
2022-12-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-07 
2022-11-23
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-21 
2022-11-02
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-12 
2022-11-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-21 
2022-07-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-03 
2022-05-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-12 
2022-03-28
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2022-03-11 
2022-01-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-16 
2021-11-18
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
2021-11-12
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
2021-10-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-10-04 
2021-08-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-27 
2021-05-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-27 
2021-03-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-16 
2021-01-12
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-10-28 
2020-12-29
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-10-28 
2020-12-10
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-10-28 
2020-11-10
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-10-28 
2020-09-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-18 
2020-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
2020-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-29 
2020-06-04
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-05-13 
2020-05-26
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-05-13 
2020-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-27 
2019-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-30 
2016-09-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-09-06